Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany · Delayed Price · Currency is EUR 0.0010
0.00 (0.00%)
At close: Jan 23, 2026
FRA:9RP Market Cap
FRA:9RP has a market cap or net worth of €690.2 thousand as of January 30, 2026. Its market cap has decreased by -57.05% in one year.
Market Cap
690.20K
Enterprise Value
-885.22K
Revenue
119.12K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since March 1, 2021, FRA:9RP's market cap has decreased from 9.62M to 690.20K, a decrease of -92.82%. That is a compound annual growth rate of -41.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 690.20K | 43.20% |
| Dec 30, 2025 | 481.98K | -67.73% |
| Dec 30, 2024 | 1.49M | -69.44% |
| Dec 29, 2023 | 4.89M | 240.47% |
| Dec 30, 2022 | 1.44M | -76.76% |
| Dec 30, 2021 | 6.18M | -35.79% |
| Mar 1, 2021 | 9.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instant Group AG | 1.32M |
| Cannovum Cannabis AG | 1.11M |
| elexxion AG | 890.65K |
| Manz AG | 820.09K |
| Epigenomics AG | 782.24K |
| Medigene AG | 649.10K |
| Paion AG | 612.07K |
| co.don AG | 427.57K |